Home › NCT07356323
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery
Who can join
Ages 22 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Subject is ≥ 22 years of age on the day of surgery. * Subject is scheduled to undergo a unilateral primary arthroplasty procedure on a hip or knee. * Subject is capable of providing informed consent. * Subject is willing and able to return for all visits. Exclusion Criteria: * Subject is pregnant or lactating prior to surgery.\* \*Women who have had surgical sterilization by a medically accepted method (e.g., tubal ligation, hysterectomy, or oophorectomy) or are post-menopausal, defined as not having menstruation for \> 12 months will not be required to undergo pregnancy testing * Subject is scheduled to undergo a lower extremity bilateral arthroplasty procedure. * Subject had a previous open knee surgery on the study knee or is scheduled to undergo a revision knee arthroplasty. * Subject has had a previous surgery for revision femoral acetabular osteotomy or total hip arthroplasty on the study hip. * Subject is scheduled for lower extremity arthroplasty due to trauma. * Subject was previously diagnosed with septic arthritis or has a history of infection in the joint. * Subject has taken any antibiotics within 4 weeks before surgery. * Subject has an allergy or sensitivity to components of the device (e.g., chlorhexidine gluconate or acrylate-based adhesive). * Subject is currently enrolled in another trial.
About the study
The goal of this clinical study is to generate data on the intended use of a chlorhexidine gluconate (CHG)-impregnated antimicrobial incise drape. The study includes subjects undergoing primary hip or knee arthroplasty procedures.
The study evaluates the intraoperative performance and safety of the incise drape during surgery, including assessment of contamination and operative characteristics.
Participants will have a CHG-impregnated antimicrobial incise drape applied during their surgical procedure. During surgery, samples will be collected from the operative site to assess potential bacterial contamination.
What is being tested
- 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG) (device)
Sponsor: Solventum US LLC · Participants: 179 · Started: Feb 19, 2026
Contact the study team
- Tracy E Swanson · Phone: 6125417752
- Stephanie Karwedsky · Phone: 6124272830
Official record on ClinicalTrials.gov — NCT07356323
Locations in the U.S.
| Indiana | Indiana University Health (IU Health), Fishers |
| Utah | University of Utah Health - Department of Orthopedics, Salt Lake City |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.